Severe cutaneous adverse reactions in a tertiary care center in Jamaica

被引:1
|
作者
Mcnish, Alicia J. S. [1 ]
Ho, Jonathan D. [1 ]
East-Innis, Althea D. C. [1 ]
机构
[1] Univ West Indies, Dept Med, Dermatol Unit, Kingston, Jamaica
来源
JAAD INTERNATIONAL | 2024年 / 15卷
关键词
acute generalized exanthematous pustulosis; drug reaction with eosinophilia and systemic symptoms; severe cutaneous drug reactions; Stevens Johnson syndrome; Stevens Johnson syndrome/toxic epidermal necrolysis overlap; toxic epidermal necrolysis; GENERALIZED EXANTHEMATOUS PUSTULOSIS; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; SYSTEMIC SYMPTOMS; EOSINOPHILIA;
D O I
10.1016/j.jdin.2024.02.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Severe cutaneous adverse reactions (SCARs) are associated with morbidity and mortality. Objective: The aim was to determine the different types of SCARs, their morphology, common offending drugs, interventions, and outcomes. Methods: A retrospective cohort study was conducted of all patients admitted to the dermatology service at the University Hospital of the West Indies with Stevens-Johnson syndrome (SJS), SJS/toxic epidermal necrolysis overlap (TEN), TEN, drug reaction with eosinophilia and systemic symptoms and acute generalized exanthematous pustulosis between January 1, 2012 to June 1, 2022. Results: Fifty-one cases (51) met the inclusion criteria for SCAR. SJS, SJS/TEN overlap and TEN together accounted for 71.2% of cases. SCARs were most frequent in the fourth, fifth and 6th decades of life and there was a female preponderance. Antibiotics (31%) and anticonvulsants (29%) were the most common causative agents for SCARs. Most patients had at least 1 complication. The liver was the most common extracutaneous organ affected. Mortality was 7.8%. The main cause of death was sepsis. Limitations: Results were not generalizable. There were missing data and loss to follow-up. Conclusion: Judicious use of antimicrobials and corticosteroids may be beneficial in treatment of severe cutaneous drug reactions. ( JAAD Int 2024;15:139-46.)
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [41] Long-term outcome of patients with severe cutaneous adverse reactions
    Kano, Yoko
    Shiohara, Tetsuo
    DERMATOLOGICA SINICA, 2013, 31 (04) : 211 - 216
  • [42] Cytokines/Chemokines: Novel Biomarkers Associated with Severe Cutaneous Adverse Reactions
    Zhang, Xiang
    Lu, Wen-Shen
    Qin, Xiao-Ming
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2020, 40 (04): : 172 - 181
  • [43] Making a diagnosis in severe cutaneous drug hypersensitivity reactions
    Ardern-Jones, Michael R.
    Mockenhaupt, Maja
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (04) : 283 - 293
  • [44] Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions
    Guvenir, Hakan
    Arikoglu, Tugba
    Vezir, Emine
    Misirlioglu, Emine Dibek
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (36) : 3840 - 3854
  • [45] Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry
    Oh, Hea Lin
    Kang, Dong Yoon
    Kang, Hye-Ryun
    Kim, Sujeong
    Koh, Young-Il
    Kim, Sae Hoon
    Kim, Min-Hye
    Suh, Dong In
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (02) : 241 - 253
  • [46] Potentially life-threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors
    Coleman, Emily
    Olamiju, Brianna
    Leventhal, Jonathan
    ONCOLOGY REPORTS, 2021, 45 (03) : 891 - 898
  • [47] Recurrence and Mortality Following Severe Cutaneous Adverse Reactions
    Finkelstein, Yaron
    Macdonald, Erin M.
    Li, Ping
    Hutson, Janine R.
    Juurlink, David N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (21): : 2231 - 2232
  • [48] Lamotrigine-induced severe cutaneous adverse reactions
    Schlienger, RG
    Shapiro, LE
    Shear, NH
    EPILEPSIA, 1998, 39 : S22 - S26
  • [49] Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics
    Lin, Ying-Fang
    Yang, Chih-Hsun
    Sindy, Hu
    Lin, Jing-Yi
    Hui, Chung-Yee Rosaline
    Tsai, Yun-Chen
    Wu, Ting-Shu
    Huang, Ching-Tai
    Kao, Kuo-Chin
    Hu, Han-Chung
    Chiu, Cheng-Hsun
    Hung, Shuen-Iu
    Chung, Wen-Hung
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (10) : 1377 - 1385
  • [50] Pharmacogenetic markers of severe cutaneous adverse drug reactions
    Borroni, R. G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2014, 149 (02): : 219 - 226